UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Epigenetic inhibitors eliminate senescent melanoma BRAFV600E cells that survive long‑term BRAF inhibition

International journal of oncology, 2020-06, Vol.56 (6), p.1429-1441

2020

Volltextzugriff (PDF)

Amplification Target ADRM1: Role as an Oncogene and Therapeutic Target for Ovarian Cancer

International journal of molecular sciences, 2013-02, Vol.14 (2), p.3094-3109

2013

Volltextzugriff (PDF)

Human leukocyte antigen-E protein is overexpressed in primary human colorectal cancer

International journal of oncology, 2008-03, Vol.32 (3), p.633-641

2008

Volltextzugriff (PDF)

Antiestrogen Fulvestrant Enhances the Antiproliferative Effects of Epidermal Growth Factor Receptor Inhibitors in Human Non–Small-Cell Lung Cancer

Journal of thoracic oncology, 2013-03, Vol.8 (3), p.270-278

2013

Volltextzugriff (PDF)

Phase II Study of Adjuvant Immunotherapy with the CSF-470 Vaccine Plus Bacillus Calmette-Guerin Plus Recombinant Human Granulocyte Macrophage-Colony Stimulating Factor vs Medium-Dose Interferon Alpha 2B in Stages IIB, IIC, and III Cutaneous Melanoma Patients: A Single Institution, Randomized Study

Frontiers in immunology, 2017-05, Vol.8, p.625-625

2017

Volltextzugriff (PDF)

Characterization of Human Cancer Cell Lines by Reverse-phase Protein Arrays

Cancer cell, 2017-02, Vol.31 (2), p.225-239

2017

Volltextzugriff (PDF)

MITF drives endolysosomal biogenesis and potentiates Wnt signaling in melanoma cells

Proceedings of the National Academy of Sciences - PNAS, 2015-02, Vol.112 (5), p.E420-E429

2015

Volltextzugriff (PDF)

Preclinical Activity of Abemaciclib Alone or in Combination with Antimitotic and Targeted Therapies in Breast Cancer

Molecular cancer therapeutics, 2018-05, Vol.17 (5), p.897-907

2018

Volltextzugriff (PDF)

A phase I clinical study of vaccination of melanoma patients with dendritic cells loaded with allogeneic apoptotic/necrotic melanoma cells. Analysis of toxicity and immune response to the vaccine and of IL-10 -1082 promoter genotype as predictor of disease progression

Journal of translational medicine, 2008-01, Vol.6 (1), p.6-6, Article 6

2008

Volltextzugriff (PDF)

WNT5A enhances resistance of melanoma cells to targeted BRAF inhibitors

The Journal of clinical investigation, 2014-07, Vol.124 (7), p.2877-2890

2014

Volltextzugriff (PDF)

Monocyte-derived dendritic cells loaded with a mixture of apoptotic/necrotic melanoma cells efficiently cross-present gp100 and MART-1 antigens to specific CD8(+) T lymphocytes

Journal of translational medicine, 2007-04, Vol.5 (1), p.19-19, Article 19

2007

Volltextzugriff (PDF)

Early Events of the Reaction Elicited by CSF-470 Melanoma Vaccine Plus Adjuvants: An In Vitro Analysis of Immune Recruitment and Cytokine Release

Frontiers in immunology, 2017-10, Vol.8, p.1342-1342

2017

Volltextzugriff (PDF)

Targeting PI3K/mTOR overcomes resistance to HER2-targeted therapy independent of feedback activation of AKT

Clinical cancer research, 2014-07, Vol.20 (13), p.3507-3520

2014

Volltextzugriff (PDF)

Reversing melanoma cross-resistance to BRAF and MEK inhibitors by co-targeting the AKT/mTOR pathway

PloS one, 2011-12, Vol.6 (12), p.e28973

2011

Volltextzugriff (PDF)

CTLA4 blockade increases Th17 cells in patients with metastatic melanoma

Journal of translational medicine, 2009-05, Vol.7 (35), p.35-35, Article 35

2009

Volltextzugriff (PDF)

Evaluation of T-Cell Responses Against Shared Melanoma Associated Antigens and Predicted Neoantigens in Cutaneous Melanoma Patients Treated With the CSF-470 Allogeneic Cell Vaccine Plus BCG and GM-CSF

Frontiers in immunology, 2020-06, Vol.11, p.1147-1147

2020

Volltextzugriff (PDF)

In vitro long-term treatment with MAPK inhibitors induces melanoma cells with resistance plasticity to inhibitors while retaining sensitivity to CD8 T cells

Oncology reports, 2017-03, Vol.37 (3), p.1367-1378

2017

Volltextzugriff (PDF)

Antitumor effects of the investigational selective MEK inhibitor TAK733 against cutaneous and uveal melanoma cell lines

Molecular cancer, 2012-04, Vol.11 (1), p.22-22, Article 22

2012

Volltextzugriff (PDF)

Combination therapy with vemurafenib (PLX4032/RG7204) and metformin in melanoma cell lines with distinct driver mutations

Journal of translational medicine, 2011-05, Vol.9 (1), p.76-76, Article 76

2011

Volltextzugriff (PDF)

Extracellular Acidosis Triggers the Maturation of Human Dendritic Cells and the Production of IL-12

Journal of Immunology, 2007-08, Vol.179 (3), p.1950-1959

2007

Volltextzugriff (PDF)

Modulation of cell signaling networks after CTLA4 blockade in patients with metastatic melanoma

PloS one, 2010-09, Vol.5 (9), p.e12711-e12711

2010

Volltextzugriff (PDF)

Cetuximab-mediated cellular cytotoxicity is inhibited by HLA-E membrane expression in colon cancer cells

Innate immunity (London, England), 2009-04, Vol.15 (2), p.91-100

2009

Volltextzugriff (PDF)

Abstract 4124: The combination of PARP inhibitor talazoparib with low-dose temozolomide results in increased cell lethality in BRCA1/2 wild-type melanoma, small cell lung cancer, ovarian, and colon cancer cell lines and mouse xenografts via the formation of DNA double-strand breaks during S-phase

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.4124-4124

2020

Volltextzugriff (PDF)

A phase I study of an allogeneic cell vaccine (VACCIMEL) with GM-CSF in melanoma patients

Journal of immunotherapy, 2006-07, Vol.29 (4), p.444-454

2006

Volltextzugriff (PDF)

A phase I trial of T-cell receptor gene therapy targeting KK-LC-1 for gastric, breast, cervical, lung and other KK-LC-1 positive epithelial cancers

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.TPS2678-TPS2678

2022

Volltextzugriff (PDF)

1 – 25 von 62

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(60)

Publikationsform

Artikel
(62)

Sprache

Englisch
(62)

Erscheinungsjahr

n.n

Thema

Science & Technology
(30)
Humans
(27)
Life Sciences & Biomedicine
(26)
Cell Line, Tumor
(16)
Oncology
(14)
Female
(11)
Melanoma
(11)
Cell Proliferation - Drug Effects
(9)
Apoptosis - Drug Effects
(8)
Mutation
(8)
Protein Kinase Inhibitors - Pharmacology
(8)
Immunology
(7)
Kinases
(7)
Male
(7)
Melanoma - Drug Therapy
(7)
Melanoma - Immunology
(7)
Melanoma - Pathology
(7)
Adult
(6)
Cell Cycle - Drug Effects
(6)
Genetic Aspects
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Epigenetic inhibitors eliminate senescent melanoma BRAFV600E cells that survive long‑term BRAF inhibition

Amplification Target ADRM1: Role as an Oncogene and Therapeutic Target for Ovarian Cancer

Human leukocyte antigen-E protein is overexpressed in primary human colorectal cancer

Antiestrogen Fulvestrant Enhances the Antiproliferative Effects of Epidermal Growth Factor Receptor Inhibitors in Human Non–Small-Cell Lung Cancer

Phase II Study of Adjuvant Immunotherapy with the CSF-470 Vaccine Plus Bacillus Calmette-Guerin Plus Recombinant Human Granulocyte Macrophage-Colony Stimulating Factor vs Medium-Dose Interferon Alpha 2B in Stages IIB, IIC, and III Cutaneous Melanoma Patients: A Single Institution, Randomized Study

Characterization of Human Cancer Cell Lines by Reverse-phase Protein Arrays

MITF drives endolysosomal biogenesis and potentiates Wnt signaling in melanoma cells

Preclinical Activity of Abemaciclib Alone or in Combination with Antimitotic and Targeted Therapies in Breast Cancer

A phase I clinical study of vaccination of melanoma patients with dendritic cells loaded with allogeneic apoptotic/necrotic melanoma cells. Analysis of toxicity and immune response to the vaccine and of IL-10 -1082 promoter genotype as predictor of disease progression

WNT5A enhances resistance of melanoma cells to targeted BRAF inhibitors

Monocyte-derived dendritic cells loaded with a mixture of apoptotic/necrotic melanoma cells efficiently cross-present gp100 and MART-1 antigens to specific CD8(+) T lymphocytes

Early Events of the Reaction Elicited by CSF-470 Melanoma Vaccine Plus Adjuvants: An In Vitro Analysis of Immune Recruitment and Cytokine Release

Targeting PI3K/mTOR overcomes resistance to HER2-targeted therapy independent of feedback activation of AKT

Reversing melanoma cross-resistance to BRAF and MEK inhibitors by co-targeting the AKT/mTOR pathway

CTLA4 blockade increases Th17 cells in patients with metastatic melanoma

Evaluation of T-Cell Responses Against Shared Melanoma Associated Antigens and Predicted Neoantigens in Cutaneous Melanoma Patients Treated With the CSF-470 Allogeneic Cell Vaccine Plus BCG and GM-CSF

In vitro long-term treatment with MAPK inhibitors induces melanoma cells with resistance plasticity to inhibitors while retaining sensitivity to CD8 T cells

Antitumor effects of the investigational selective MEK inhibitor TAK733 against cutaneous and uveal melanoma cell lines

Combination therapy with vemurafenib (PLX4032/RG7204) and metformin in melanoma cell lines with distinct driver mutations

Extracellular Acidosis Triggers the Maturation of Human Dendritic Cells and the Production of IL-12

Modulation of cell signaling networks after CTLA4 blockade in patients with metastatic melanoma

Cetuximab-mediated cellular cytotoxicity is inhibited by HLA-E membrane expression in colon cancer cells

Abstract 4124: The combination of PARP inhibitor talazoparib with low-dose temozolomide results in increased cell lethality in BRCA1/2 wild-type melanoma, small cell lung cancer, ovarian, and colon cancer cell lines and mouse xenografts via the formation of DNA double-strand breaks during S-phase

A phase I study of an allogeneic cell vaccine (VACCIMEL) with GM-CSF in melanoma patients

A phase I trial of T-cell receptor gene therapy targeting KK-LC-1 for gastric, breast, cervical, lung and other KK-LC-1 positive epithelial cancers

Suchergebnisse filtern